Skip to content

Clear Care Clear Care 2x12oz (UDI 00047113609027)Recalls & reported problems

Alcon Laboratories, Inc. · Clear Care Cleaning & Disinfecting Solution Twin Pack 2 x 12 oz. · Class 2

All models of Clear Care (5)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00047113609027), received between Oct 8, 2020 and Jul 23, 2025 — classified as 4 injuries.

The most frequently reported specific device problem is “Improper Chemical Reaction” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Improper Chemical Reaction1
  • Patient-Device Incompatibility1
  • Use of Device Problem1

Patient problems

  • Blurred Vision2
  • Corneal Abrasion2
  • Corneal Ulcer2
  • Eye Irritation2
  • Eye Pain2
  • Photophobia2
  • Red Eye(s)2
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 23, 2025Improper Chemical Reaction; Improper Chemical Reaction

    AS INITIALLY THE REPORTED BY THE CONSUMER STATING THAT THE CONSUMER EXPERIENCED SERIOUS EYE INJURY CAUSED BY THE CONTACT LENS SOLUTION EVEN AFTER FOLLOWING ALL INSTRUCTION AND NEUTRALIZING. THE CUSTOMER SUFFERED A CHEMICAL BURN TO THE EYE, WHICH LED TO A RUPTURED AND ONE MM MARGINAL CORNEAL ULCER IN THE LEFT EYE. THE INJURY REQUIRED MULTIPLE DOCTOR VISITS, PRESCRIPTIONS FOR ANTIBIOTIC AND STEROID EYE DROPS, AND WEEKS WITHOUT BEING ABLE TO WEAR CONTACT LENSES. CUSTOMER HAD TO WEAR GLASSES, WHICH IMPACTED THE VISION. THE CONTACT LENS CARE SUDDENLY STOPPED NEUTRALIZING PROPERLY WHICH RESULTED IN VISION PROBLEM IN ONE EYE. THE INJURY HAD RESULTED IN BLURRY VISION IN THE AFFECTED EYE ALONG WITH DISCOMFORT EVENT AFTER MEDICAL TREATMENT. DURING FOLLOW UP IT WAS ALSO DIAGNOSED TO HAVE CORNEAL KERATITIS. THE CURRENT STATUS OF THE CONSUMER'S EYE IS SYMPTOM RESOLVED AND THE CUSTOMER HAS RESUMED CONTACT LENS WEAR. NO ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision; Corneal Ulcer; Discomfort; Eye Burn; Eye Irritation; Eye Pain; Keratitis; Photophobia; Red Eye(s)

    MAUDE report 22573552 ↗
  • InjuryOct 28, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AS INITIALLY REPORTED FROM ATTORNEY TO LEGAL TEAM ON BEHALF OF THE CONSUMER STATING THAT CONSUMER EXPERIENCED FOREIGN BODY SENSATION, BLURRED VISION, PAIN, PHOTOPHOBIA, AND RED EYE, WHICH WERE SEVERE IN NATURE IN RELATION TO THE RIGHT EYE (OD) FOR DURATION OF THREE WEEKS. CONSUMER SOUGHT MEDICAL ATTENTION FOR THE ABOVE SYMPTOMS. ON SLIT EXAMINATION OD HAD FOLLOWING FINDINGS GRANULAR KERATITIS (POORLY DEFINED WHITENING/ GREYING, NO WELL-DEFINED INFILTRATE) (1.2MM(V) X 2.0(H)) EPITHELIAL DEFECT. DIFFERENTIAL DIAGNOSIS OF HERPES SIMPLEX VIRUS, BACTERIAL, FUNGAL AND ACANTHAMOEBA WAS CONSIDERED. ADVISED FOR CORNEAL CULTURE AND CORNEAL PCR (POLYMERASE CHAIN REACTION) TESTS . DIAGNOSIS OF CENTRAL CORNEAL ULCER OF OD WAS PROVIDED FROM THE EYE CARE PROFESSIONAL (ECP).SHE WAS PRESCRIBED WITH MOXIFLOXACIN 0.5 % EYE DROPS, TO BE APPLIED ONE DROP IN THE RIGHT EYE EVERY TWO HOURS TILL NEXT VISIT, ERYTHROMYCIN 5 MG/GRAM (0.5 %) EYE OINTMENT, TO BE ADMINISTERED PEA-SIZED AMOUNT INTO RIGHT EYE THREE TIMES DAILY TILL NEXT VISIT., VALACYCLOVIR TABLET;1 GRAM, TO BE TAKEN ORALLY THREE TIMES DAILY TILL NEXT VISIT AND ADVISED FOR FOLLOW UP AFTER TWO DAYS FOR FURTHER EVALUATION AND MANAGEMENT . CONSUMER W

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Blurred Vision; Corneal Abrasion; Corneal Infiltrates; Corneal Ulcer; Erosion; Eye Irritation; Eye Pain; Infective Keratitis; Iritis; Photophobia; Ptosis; Purulent Discharge; Red Eye(s)

    MAUDE report 20542404 ↗
  • InjuryApr 13, 2023Use of Device Problem; Use of Device Problem

    NON-HEALTH CARE PROFESSIONAL REPORTED ON BEHALF OF A CONSUMER, WHO EXPERIENCED SEVERE DAMAGE TO THE PUPIL, LOSS OF VISION IN LEFT EYE AND SIGNIFICANT DISTRESS AFTER USING CLEANING AND DISINFECTING SOLUTION. THE CONSUMER USED THE EXPIRED PRODUCTS. THE CURRENT STATUS OF THE CONSUMER'S EYE IS NOT RESOLVED AT THE TIME OF THIS REPORT. ADDITIONAL INFORMATION HAS BEEN REQUESTED BUT NOT YET RECEIVED.

    Patient problems: Corneal Abrasion; Distress; Loss of Vision

    MAUDE report 16730075 ↗
  • InjuryOct 8, 2020Patient-Device Incompatibility

    CONSUMER CALLED TO REPORT THAT AFTER USING CLEAR CARE 3% HYDROGEN PEROXIDE CLEAN AND DISINFECTANT SOLUTION (OPHTHALMIC SOLUTION), SHE EXPERIENCED SEVERE EYE BURNING AND WATERY EYES. CONSUMER BELIEVES THAT THE DISC THAT IS SUPPOSED TO BE AT THE BOTTOM OF THE SOLUTION BOTTLE, DOES NOT LAST FOR THE DURATION OF THE PRODUCT, SO THE SOLUTION NO LONGER IS BEING NEUTRALIZED. CONSUMER HAS CONTACTED THE MANUFACTURER VIA EMAIL, AND HAS YET TO RECEIVE A RESPONSE. SHE HAS AUTHORIZED FDA TO PROVIDE HER NAME IN ORDER TO FACILITATE THE COMPLAINT FOLLOW-UP. EYE IRRITATION.

    Patient problems: Burning Sensation; Excessive Tear Production; Irritation

    MAUDE report 10658443 ↗

Other Accessories, soft lens products devices

All Accessories, soft lens products devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page